PDF
(Download)
|
- Lavender (Lavandula angustifolia)
- Anxiety
| Date:
08-15-2012 | HC# 051254-454
|
Re: Review of Studies Assessing the Effect of Lavender on Anxiety
Perry
R, Terry R, Watson LK, Ernst E. Is lavender an anxiolytic drug? A systematic
review of randomised clinical trials. Phytomed.
June 15, 2012;19(8-9):825-835.
Oral, olfactory, and topical lavender (Lavandula angustifolia) is used for its anxiolytic and calming
properties. Lavender contains linalool and linalyl acetate, which may be responsible
for its anxiolytic properties. The purpose of this systematic review was to
critically evaluate the data from randomized, clinical trials (RCTs) of all
types of lavender preparations (oral, olfactory, and topical) for the treatment
of anxiety.
MEDLINE, EMBASE, PsycINFO, AMED, CINAHL, The Cochrane Library,
and the ISI Web of Knowledge databases were searched from inception to December
2010. Lavender and anxiety or stress were the search terms, along with 74 other
possible combinations of related search terms. Reference lists of the selected
articles were also searched. The authors included only RCTs in which human
subjects with or without clinical anxiety were treated with any type of
lavender monopreparation, and those that reported validated measures of anxiety
or stress as an endpoint, standardized measures of anxiety, or physiological
measures of stress. There were no language restrictions. Methodological quality
was assessed with the Jadad score (0 to 5, with 5 being the highest quality). A
meta-analysis was not possible because of the heterogeneity of the included
studies.
The literature search
identified 440 potentially relevant articles, but only 15 RCTs met the
inclusion criteria. The 15 trials included a total of 1565 subjects (n = 16-340
per study), originated from 6 countries, and all were written in English. The
methodological quality was mostly poor; only two studies had a Jadad score of
4, two studies had a score of 2, 9 studies had a score of 1, and two studies
had a score of 0.
Eight studies evaluated inhalation of lavender, with four of
the studies reporting a positive finding on at least one anxiety measure. Four
of the inhalation studies did not demonstrate an effect. All of the inhalation studies
were of poor quality, which limits the value and credibility of the studies. Two
studies used aromatherapy massage. One of the two studies found a positive
effect compared with no massage, but there was no difference when lavender oil
massage was compared with control oil massage. The second study found no effect
of massage with lavender oil compared with massage without the lavender. Both aromatherapy
massage studies were of poor quality, according to the authors. One study used
an Ayurvedic oil-dripping technique where lavender oil was poured over the
forehead. There was no significant difference between lavender oil and the
carrier oil on anxiety levels. One study used bathing in lavender oil compared
to bathing without oil. There was no significant difference between treatment
groups in anxiety scores.
Three studies evaluated oral lavender. Two of these studies
received a Jadad score of 4. In a double-blind RCT, an oral lavender oil preparation
(Silexan®; Dr. Willmar Schwabe GmbH; Karlsruhe, Germany) was as
effective as the anxiolytic lorazepam. In a placebo-controlled, double-blind randomized
trial, oral lavender oil capsules (Silexan) decreased 'subsyndromal' anxiety
disorder (according to the DSM-IV or ICD-10) symptoms significantly more than
placebo (P < 0.01). A third study (of poorer quality) conducted with healthy
subjects concluded that oral lavender may have an effect on general anxiety
states but not when the levels of anxiety get too high.
Only 5 of the 15 studies recorded adverse events. Patients
treated with oral lavender reported adverse gastrointestinal effects (details
not reported), although in one of the high-quality clinical trials, the
quantity of the adverse events was comparable to the placebo group. The current
data from the clinical trials under review suggest that lavender seems to be a well-tolerated
alternative to benzodiazepines. Nonetheless, the authors state that lavender
should be used with caution because lavender oil can be a powerful allergen.
The authors caution that all of the results should be
considered in the context of their methodological limitations. Although there
may be beneficial effects of lavender on anxiety measures, methodological
issues limit the extent to which firm conclusions can be drawn. The authors
state, "The evidence for oral lavender is promising but, until independent
replications emerge with long-term follow-up data, remains inconclusive."
They conclude that the use of any other form of lavender (aromatherapy,
inhalation, and massage) is not currently supported by good evidence of efficacy.
To elucidate the therapeutic value of lavender as an anxiolytic, future trials
must be methodologically rigorous.
—Heather
S. Oliff, PhD
|